Statistics
Publications
3
Citations
269
H-Index
3
Active since
2004
Affiliations
L. Billings is an author at The University of Texas MD Anderson Cancer Center specializing in malignant neoplasms, tyrosine kinase inhibitors, and metastasis.
Publications per year
2004–2008
3
3
Phase II trial of imatinib mesylate in patients with metastatic melanoma
KYOUNG‐MEE KIM, Omar Eton, Darren W. Davis et al. · British Journal of Cancer · 2008 · 215 citations · Full text
Medicine, Oncology, Immunotherapy +16
Phase II trial of imatinib mesylate (STI-571) in metastatic melanoma (MM)
Omar Eton, L. Billings, K. Kim et al. · Journal of Clinical Oncology · 2004 · 42 citations
Medicine, Cancer Biology, Oncology +16
Phase II trial of imatinib mesylate (STI-571) in metastatic melanoma (MM)
Omar Eton, L. Billings, K. Kim et al. · Journal of Clinical Oncology · 2004 · 12 citations
Medicine, Cancer Biology, Oncology +16
1–3 of 3